Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin or aspirin-dipyridamole for preventing serious vascular events in high risk patients

Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin or aspirin-dipyridamole for preventing serious vascular events in high risk patients is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central